SCOTTSDALE, Ariz. – August 4, 2016 – 21st Century Oncology of Arizona is proud to announce that Board Certified Radiation Oncologist, Ajay Bhatnagar, M.D., MBA, has been named Research Director for 21st Century Oncology’s cancer treatment centers in Arizona.
Dr. Bhatnagar will oversee research operations at 21st Century Oncology’s location in Scottsdale. Since the research program began, many patients have had access to cutting-edge clinical trials close to home in Scottsdale. The program will now have three Board Certified Radiation Oncologists as sub-investigators: Anderson Bauer, M.D., Vershalee Shukla, M.D. and Abhilash Nambiar, M.D.
With a background in biomedical engineering, Dr. Bhatnagar has a broad range of experience in new cancer care technologies and research. He has written numerous publications, specifically regarding the modern technological developments in radiation oncology, with his most recent work on development of electronic brachytherapy for the treatment on non-melanoma skin cancer.
After earning his medical degree from the University of Pittsburgh School of Medicine, Dr. Bhatnagar went on to earn an MBA degree from the University of Pittsburgh Katz Graduate School of Business. He completed residency training in radiation oncology at the University of Pittsburg Cancer Institute, where he served as chief resident. In addition to his new role as Research Director, Dr. Bhatnagar will continue serving as Medical Director for 21st Century Oncology’s five Phoenix-area locations.
21st Century Oncology is currently conducting various research studies, with open enrollment in clinical trials for prostate and bladder cancer patients and is an active member of the cooperative research group NRG.
21st Century Oncology Scottsdale is located at 7340 E. Thomas Road.
For more information about our services, visit www.21co.com/Arizona or call (480) 874-8495.
About 21st Century Oncology:
21st Century Oncology is the largest global, physician led provider of Integrated Cancer Care services. The company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of December 31, 2015, the Company operated 181 treatment centers, including 145 centers located in 17 U.S. states and 36 centers located in seven countries in Latin America. The company holds market-leading positions in most of its domestic local markets and abroad.